Obesity, smoking tied to 5-FU-induced cardiotoxicity in cancer patients
Smoking, obesity, treatment duration, and pre-existing cardiac diseases may contribute to the development of cardiotoxicity among patients with cancer who are undergoing 5-fluorouracil (5-FU) chemotherapy, suggests a recent study. “[W]ell-defined risk factors and their possible mechanisms should be identified and evaluated on a clinical basis and put together into a model for risk stratification, which could …
Obesity, smoking tied to 5-FU-induced cardiotoxicity in cancer patients Read More »
